Gideon Pharmaceuticals' Acquisition

Gideon Pharmaceuticals was acquired by Elorac on April 15, 2016.

Gideon Pharmaceuticals' development-stage pharmaceutical products employ the patented Heprotect technology, which reduces the hepatotoxicity of hepatocellular toxic agents without interfering with bio…

Articles about Gideon Pharmaceuticals' Acquisition: